Dashboard
Poor long term growth as Net Sales has grown by an annual rate of -6.84% and Operating profit at -173.26% over the last 5 years
The company has declared Negative results for the last 7 consecutive quarters
Stock is technically in a Bearish range
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
INR 107 Cr (Micro Cap)
26.00
37
3.36%
-0.54
2.90%
0.76
Total Returns (Price + Dividend) 
Latest dividend: 3.511197440585009 per share ex-dividend date: Sep-23-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Tyche Industries Ltd is Rated Strong Sell
Tyche Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 19 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Tyche Industries Ltd is Rated Strong Sell
Tyche Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 August 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are based on the company’s current position as of 31 October 2026, providing investors with the latest comprehensive analysis.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSENewspaper publication of Financial Results for the 2nd Quarter and Half Year ended September 30 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On November 13 2026
13-Nov-2026 | Source : BSEApproval of Unaudited Financial Results for the quarter and half-year ended September 30 2026
Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2026.
13-Nov-2026 | Source : BSEUn-Audited Financial Results for the Quarter and Half Year ended September 30 2026.
Corporate Actions 
No Upcoming Board Meetings
Tyche Industries Ltd has declared 35% dividend, ex-date: 23 Sep 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Silver Oak Technologies Private Limited (19.31%)
Plutus Techlabs Private Limited (6.4%)
27.06%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 55.82% vs -43.83% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 2,950.00% vs -103.48% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -25.51% vs 8.98% in Sep 2024
Growth in half year ended Sep 2025 is -41.22% vs 14.87% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -30.42% vs -2.71% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -49.65% vs 13.02% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -18.08% vs -5.81% in Mar 2025
YoY Growth in year ended Mar 2026 is -44.08% vs 1.39% in Mar 2025
